Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30051060HIVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS30051061HIVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS30051062HIVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS20054890HPVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS20018873HPVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS20035307HPVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS20023178HPVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS20054582HPVENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS44030948HTLV-1ENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TVIS44029588HTLV-1ENSG00000071054.17protein_codingMAP4K4YesNo9448O95819
TCGA Plot Options
Drug Information
GeneMAP4K4
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009473
UniProt IDO95819
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830